Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04553484 · ClinicalTrials.gov registry record
Measuring Cardiovascular Performance and Blood Flow Using Common But Never Compared Methods.
A clinical trial of D012039 and D001775, sponsored by Semler Scientific.
- Completed
- Registry status
- 657
- Enrollment target
- 4
- Study locations
NCT04553484: Completed study of D012039 and D001775, sponsored by Semler Scientific.
NCT04553484 is a study of D012039 and D001775 that has completed, run by Semler Scientific. The registered enrollment target is 657 participants. The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04553484, a study of D012039 and D001775, has completed, sponsored by Semler Scientific.
- COMPLETED
- Registry status
- 657 participants
- Enrollment target
- 4
- Study locations
Study Summary
Measuring Cardiovascular Performance Using Common Methods in subjects.
Primary Outcome
The feasibility of performing three common tests, Echocardiography (Echo), Brain Natriuretic Peptide (BNP) and volume plethysmography (VP), in the same subject was assessed. Each of the 657 participants were submitted to a brief non-invasive blood flow and cardiac performance test (plethysmography (VP) and Echocardiography (Echo)). Each of the 236 participants were subject to blood drawn test, Brain Natriuretic Peptide (BNP).
Interventions
- DIAGNOSTIC_TEST No intervention
Study Locations (4)
Texas
- JF Southwest Heart Clinic, P.A. - Houston
- Southwest Clinical Trials - Houston
Georgia
- Middle Georgia Heart and Vascular Center - Macon
Nebraska
- Integrated Cardiology Group, LLC, d/b/a Bryan Heart - Lincoln
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 657 participants |
| Start Date | 2020-08-05 |
| Est. Completion | 2022-01-14 |
What the finished NCT04553484 record still lists
NCT04553484 is an observational study that tracks outcomes without assigning an intervention. The registered 657 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with D012039 appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT04553484 reports a single indexed study location in Texas, Georgia, Nebraska.
Frequently Asked Questions
What is clinical trial NCT04553484 about?
NCT04553484 is a clinical study titled "Measuring Cardiovascular Performance and Blood Flow Using Common But Never Compared Methods.". Measuring Cardiovascular Performance Using Common Methods in subjects.
What is the current status of trial NCT04553484?
This trial is currently completed. The enrollment target is 657 participants. The study started on 2020-08-05. Estimated completion is 2022-01-14.
What conditions does trial NCT04553484 study?
This clinical trial studies the following conditions: D012039, D001775.
What interventions are being tested in trial NCT04553484?
The interventions under investigation include: No intervention (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04553484?
This trial is sponsored by Semler Scientific, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04553484 being conducted?
This trial has 4 study locations across Georgia, Nebraska, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03671044 · 657 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
- NCT05338697 · 657 participants
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
- NCT05407129 · 656 participants · NA
Patients and Families Improving Safety in Hospitals by Actively Reporting Experiences
- NCT06127199 · 656 participants · NA
Contraceptive Efficacy Study of Ovaprene
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI